Non-Conforming Pz-Cel Surgical Application To Rdeb Wounds, Additional Biopsies, Pz-Cel Surgical Application To Deb Wounds
Epidermolysis Bullosa (Eb), Recessive Dystrophic Epidermolysis Bullosa (Rdeb), Dystrophic Epidermolysis Bullosa (Deb)
Phase IV
Not Yet Recruiting
Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds
Jul 16, 2026
―
Pz-Cel, Eb-101 Surgical Application Of Rdeb Wounds
Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, Rdeb
Phase III
Active Not Recruiting
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients
Jan 23, 2023
―
Eb-101
Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa
Phase III
Completed
Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Jan 10, 2020
―
Abo-102
Mps Iiia, Sanfilippo Syndrome, Sanfilippo A, Mucopolysaccharidosis Iii
Phase I/II
Terminated
Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease
Sep 11, 2019
―
Raav9.Cmv.Hnaglu
Mucopolysaccharidosis Type 3 B
Phase I/II
Terminated
Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB
Oct 10, 2017
―
Ux111, Prophylactic Immunomodulatory Therapy, Optimized Prophylactic Im Therapy, Adjuvant Im Therapy
Mps Iiia, Sanfilippo Syndrome, Sanfilippo A, Mucopolysaccharidosis Iii
Phase II/III
Recruiting
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
Mar 17, 2016
―
Lzrse-Col7a1 Engineered Autologous Epidermal Sheets
Epidermolysis Bullosa, Epidermolysis Bullosa Dystrophica
Phase I/II
Completed
Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Dec 15, 2010
―
Ofloxacin, Msi-78
Diabetic Foot Ulcers
Phase III
Completed
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
Nov 21, 2007
―
Ofloxacin, Msi-78
Diabetic Foot Ulcers
Phase III
Completed
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
Nov 21, 2007
―
Econail
Onychomycosis
Phase II
Completed
A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail
Oct 05, 2006
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Abeona Therapeutics (PCJ) have in its pipeline
PCJ is currently developing the following drugs: Non-Conforming Pz-Cel Surgical Application To Rdeb Wounds, Additional Biopsies, Pz-Cel Surgical Application To Deb Wounds, Pz-Cel, Eb-101 Surgical Application Of Rdeb Wounds, Eb-101. These drug candidates are in various stages of clinical development as the company works toward FDA approval.